Key result
Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock was fully reversible clinically and on cardiac magnetic resonance imaging 6 weeks after discharge.
Why the study?
Takotsubo cardiomyopathy is an extremely rare and potentially fatal complication of fluorouracil-containing chemotherapy regimens with infrequent presence in the literature, warranting review of its clinical features and outcomes.
Population
A 54-year-old lady with cardiogenic shock and fluorouracil-induced Takotsubo cardiomyopathy
Design
Case report
Follow-up
6 weeks following discharge
Authors
Loading...
Emphasizes the need for prompt recognition of severe fluorouracil cardiotoxicity to.
Case Report (n=1)
Highlights the rare but potentially fatal cardiotoxicity of fluorouracil causing Takotsubo cardiomyopathy, which can be fully reversible with prompt management.
Joy et al. (2019) conducted a case report in Takotsubo cardiomyopathy and cardiogenic shock (n=1). Fluorouracil-containing chemotherapy (FOLFOX) was evaluated on Clinical and cardiac magnetic resonance imaging recovery. Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock was fully reversible clinically and on cardiac magnetic resonance imaging 6 weeks after discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: